Catalyst Wire Dossier Catalyst Wire Dossier

LY9999QS

· Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY9999QS, covering 2018-03-29 to 2018-03-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants [Phase 1]

See pricing